Alveolar macrophage populations are distorted in immunocompromised patients with pneumonitis.
Alveolar macrophages (AM) were obtained by bronchoalveolar lavage (BAL) from patients presenting with pneumonitis: 30 human immunodeficiency virus (HIV)-infected individuals and 12 transplant recipients. Nine normal volunteers acted as controls. The cells were washed and cytospins prepared. Monoclonal antibodies (MoAbs) and immunoperoxidase methods were used to analyse the expression of HLA-DR molecules as well as phenotypic macrophage markers. P values apply to the differences between medians using the Mann-Whitney test. Median percentages of macrophages, lymphocytes and neutrophils were similar in all three groups. No differences were found in the median percentages of macrophages expressing the monocyte phenotype (MoAb UCHM1, CD14). However, in HIV-infected patients and transplant recipients a median of only 45% of macrophages expressed the pan-macrophage phenotype identified by MoAb EBM11 (CD68) in contrast with 98% in the normal volunteers. The AM population expressing the dendritic cell marker (MoAb RFD1) was also markedly reduced in both groups of immunocompromised patients (2 vs 28% in normal volunteers). Transplant recipients had significantly more phagocytic cells identified by MoAb RFD7 than the HIV-infected patients (25 vs 2%), but the numbers were still low when compared with the volunteers (48%). HLA-DR expression on BAL cells was reduced by 90% in both immunocompromised groups. For the transplant recipients, severity of pneumonitis was correlated with expression of dendritic cell marker RFD1, (Spearman's rank correlation r = 0.538, p less than 0.05) and pan-macrophage marker EBM11 (r = 0.581, p less than 0.05), while no such correlation was found in HIV-infected patients. These results suggest that a defective macrophage population is probably a serious factor contributing to immunosuppression.
Bray
D H
DH
Dept of Clinical Immunology, Royal Free Hospital and School of Medicine, London, UK.
Squire
S B
SB
Bagdades
E
E
Mulvenna
P M
PM
Johnson
M A
MA
Poulter
L W
LW
D000328:Adult; D001992:Bronchoalveolar Lavage Fluid / Q000276:immunology / Q000382:microbiology; D015496:CD4-Positive T-Lymphocytes; D015870:Gene Expression; D005819:Genetic Markers; D015658:HIV Infections / Q000150:complications / Q000276:immunology*; D006684:HLA-DR Antigens / Q000235:genetics; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology*; D007958:Leukocyte Count; D016676:Macrophages, Alveolar; D010641:Phenotype; D011014:Pneumonia / Q000209:etiology / Q000276:immunology*; D011446:Prospective Studies
D005819:Genetic Markers; D006684:HLA-DR Antigens